KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Amortization - Deferred ChargesCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Gsk (GSK) Gross Profit (2016 - 2026)

Gsk has reported Gross Profit over the past 18 years, most recently at $7.8 billion for Q1 2026.

  • For Q1 2026, Gross Profit rose 10.4% year-over-year to $7.8 billion; the TTM value through Mar 2026 reached $31.9 billion, down 11.07%, while the annual FY2025 figure was $31.5 billion, 9.77% up from the prior year.
  • Gross Profit for Q1 2026 was $7.8 billion at Gsk, down from $7.9 billion in the prior quarter.
  • Over five years, Gross Profit peaked at $14.3 billion in Q4 2024 and troughed at $6.0 billion in Q2 2022.
  • A 5-year average of $8.0 billion and a median of $7.3 billion in 2024 define the central range for Gross Profit.
  • On a YoY basis, Gross Profit climbed as much as 24.33% in 2022 and fell as far as 51.44% in 2022.
  • Year by year, Gross Profit stood at $10.8 billion in 2022, then increased by 17.61% to $12.7 billion in 2023, then increased by 12.5% to $14.3 billion in 2024, then plummeted by 44.62% to $7.9 billion in 2025, then dropped by 2.17% to $7.8 billion in 2026.
  • Business Quant data shows Gross Profit for GSK at $7.8 billion in Q1 2026, $7.9 billion in Q4 2025, and $8.5 billion in Q3 2025.